Up-regulation of the fidelity of human DNA polymerase lambda by its non-enzymatic proline-rich domain

J Biol Chem. 2006 Jul 14;281(28):19038-44. doi: 10.1074/jbc.M601178200. Epub 2006 May 4.

Abstract

DNA repair pathways are essential for maintaining genome stability. DNA polymerase beta plays a critical role in base-excision repair in vivo. DNA polymerase lambda, a recently identified X-family homolog of DNA polymerase beta, is hypothesized to be a second polymerase involved in base-excision repair. The full-length DNA polymerase lambda is comprised of three domains: a C-terminal DNA polymerase beta-like domain, an N-terminal BRCA1 C-terminal domain, and a previously uncharacterized proline-rich domain. Strikingly, pre-steady-state kinetic analyses reveal that, although human DNA polymerase lambda has almost identical fidelity to human DNA polymerase beta, the C-terminal DNA polymerase beta-like domain alone displays a dramatic, up to 100-fold loss in fidelity. We further demonstrate that the non-enzymatic proline-rich domain confers the increase in fidelity of DNA polymerase lambda by significantly lowering incorporation rate constants of incorrect nucleotides. Our studies illustrate a novel mechanism, in which the DNA polymerase fidelity is controlled not by an accessory protein or a proofreading exonuclease domain but by an internal regulatory domain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cloning, Molecular
  • DNA Polymerase beta / biosynthesis*
  • DNA Polymerase beta / genetics
  • DNA Repair
  • Dose-Response Relationship, Drug
  • Humans
  • Kinetics
  • Models, Chemical
  • Molecular Sequence Data
  • Proline / chemistry*
  • Protein Structure, Tertiary
  • Up-Regulation*

Substances

  • Proline
  • DNA polymerase beta2
  • DNA Polymerase beta